KMG Chemicals Reports Second Quarter 2013 Financial Results
KMG Chemicals Reports Second Quarter 2013 Financial Results
HOUSTON--(BUSINESS WIRE)-- KMG Chemicals, Inc. (NYS: KMG) , a global provider of specialty chemicals in select markets, today announced financial results for the fiscal 2013 second quarter ended January 31, 2013.
2013 Second Fiscal Quarter Highlights
Net sales were $57.0 million, down 15.0% from the comparable quarter in fiscal 2012, reflecting reduced demand within our Electronic Chemicals and Wood Treating Chemicals businesses.
Gross profit margins increased to 27.6%, from 25.6% in the second fiscal quarter of 2012.
Operating income declined to $3.2 million, from $4.9 million in the same period a year ago.
Diluted earnings per share were $0.14 vs. $0.21 per share in last year's second fiscal quarter.
Electronic Chemicals segment operating margins (after corporate allocations) improved slightly to 6.8% vs. 6.5% in the second fiscal quarter of 2012.
Wood Treating Chemicals segment operating margins (after corporate allocations) declined to 10.5% vs. 11.5% in last year's second quarter.
Neal Butler, President and CEO of KMG, commented, "Weakness in North American semiconductor production and reduced demand for our wood treating chemicals caused our second quarter results to come in below our original expectations. Additionally, expenses associated with the advancement of our consolidation strategy weighed on our bottom line results. Despite the challenging operating environment and the related impact to our shipment volumes, our gross profit margins increased by 200 bps on a year-over-year basis, reflecting benefits from our targeted pricing, cost savings and efficiency improvement initiatives undertaken over the past twelve months."
Electronic Chemicals
Electronic Chemicals sales were $35.6 million, down $3.0 million, or 7.8%, as compared to $38.6 million for the prior year period. The sales decline reflected reduced volumes as semiconductor manufacturers reduced inventories and slowed production in response to softer consumer demand for high-tech electronic devices.
Despite the reduction in second quarter volumes, segment operating margins rose 30 bps year-over-year to 6.8%, benefiting from the realization of previous pricing adjustments undertaken in response to higher raw materials costs and from efficiency gains from our continual improvement initiatives.
Wood Treating Chemicals
Wood Treating Chemicals sales were $21.2 million, down $7.2 million, or 25.4%, from $28.4 million in the second fiscal quarter of 2012. The decline in segment sales reflected competitive pressures from alternative processes and treatments in the rail tie treating market as well as a temporary drop in demand from our utility pole treating customers. The second fiscal quarter results were also adversely impacted by unplanned interruptions at customers' wood treating facilities.
Segment operating margins were 10.5%, down 100 bps from 11.5% in last year's second quarter. The reduction in segment operating margins was attributable to lower volumes and the associated impact of lower volumes on segment profitability.
Balance Sheet and Cash Flow Overview
John V. Sobchak, CFO of KMG, said, "Our balance sheet remained strong in the second quarter, with $52.0 million in working capital and cash of $5.5 million. Shareholders' equity increased to $114.3 million in the second quarter, up from $100.5 million in the same period a year ago, and we have reduced our long-term debt by $19 million during the same time period. As a result, our long-term debt-to-shareholders' equity ratio of 19.2% is now at its lowest level since the first quarter of 2008, providing us with significant financial flexibility to pursue our consolidation strategy. Importantly, KMG remained solidly cash flow positive, generating net cash from operating activities of $8.6 million for the six months ended January 31, 2013."
Outlook
Commenting on the outlook, Mr. Butler said, "We are encouraged by recent trends in our Electronic Chemicals business, which has benefited from strengthening customer demand and improved volumes thus far in calendar 2013. This rebound in production should have a positive impact on third fiscal quarter segment margins, and we anticipate operating profits will improve notably from those reported in the second quarter of fiscal 2013. In our Wood Treating Chemicals segment, we anticipate third fiscal quarter volumes will show improvement relative to those in the second quarter of 2013, though segment sales will remain below the level reported in the third quarter of fiscal 2012. Given the anticipated increase in fiscal third quarter Wood Treating Chemicals volumes, we expect segment operating profits will improve accordingly. Overall, we estimate third fiscal quarter diluted earnings per share will be approximately 70% of the prior year's third quarter diluted earnings per share of $0.33 from continuing operations. We believe a rebound in demand will remain into the fourth quarter."
Mr. Butler concluded, "As we enter the second half of fiscal 2013, we are optimistic about our prospects, not only for the current third fiscal quarter but for the longer term as well. We remain confident in our consolidation strategy, as we continue to identify, evaluate and pursue key opportunities - including the establishment of a new market platform in fiscal 2014 -- that will drive earnings growth, increase cash flow and create lasting value for our shareholders."
Conference Call
Date: Friday, March 8, 2013
Time: 10:00 a.m. EST
Dial-in: 800-561-2693 or 617-614-3523
Participant passcode: 57079806
The conference call will also be webcast live via the "Investors" section of the Company's website at http://kmgchemicals.com. To listen to the live call, please go to the website at least 15 minutes early to register, download and install any necessary audio software.
If you are unable to listen live, the conference call will be archived on the KMG website. A telephone replay of the call will also be available for one week, starting at 12:00 p.m. ET on March 8, 2013. To access the call, dial 888-286-8010 or 617-801-6888 using participant passcode 51894882.
About KMG
KMG Chemicals, Inc., through its subsidiaries, produces and distributes specialty chemicals to select markets. The Company grows by acquiring and optimizing stable chemical product lines and businesses with established production processes. Its current operations are focused on the electronic and industrial wood treatment chemical markets. For more information, visit the Company's website at http://kmgchemicals.com.
The information in this news release includes certain forward-looking statements that are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including statements as to the future performance of the company. Although the company believes that the expectations reflected in its forward-looking statements are reasonable, it can give no assurance that such expectations or any of its forward-looking statements will prove to be correct. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, product development acceptance, the impact of competitive services and pricing and general economic risks and uncertainties.
KMG CHEMICALS, INC. AND SUBSIDIARIES | ||||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF INCOME | ||||||||||||||||
(UNAUDITED) | ||||||||||||||||
(In thousands, except for per share amounts) | ||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||
January 31, | January 31, | |||||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||
Net sales | $ | 56,959 | $ | 66,976 | $ | 122,295 | $ | 138,515 | ||||||||
Cost of sales | 41,238 | 49,835 | 86,486 | 102,699 | ||||||||||||
Gross profit | 15,721 | 17,141 | 35,809 | 35,816 | ||||||||||||
Distribution expenses | 5,922 | 5,802 | 12,975 | 11,872 | ||||||||||||
Selling, general and administrative expenses | 6,603 | 6,456 | 12,534 | 12,070 | ||||||||||||
Operating income | 3,196 | 4,883 | 10,300 | 11,874 | ||||||||||||
Other income/(expense) | ||||||||||||||||
Interest expense, net | (395 | ) | (555 | ) | (806 | ) | (1,105 | ) | ||||||||
Other, net | (76 | ) | (72 | ) | (126 | ) | (147 | ) | ||||||||
Total other expense, net | (471 | ) | (627 | ) | (932 | ) | (1,252 | ) | ||||||||
Income from continuing operations before income taxes | 2,725 | 4,256 | 9,368 | 10,622 | ||||||||||||
Provision for income taxes | (1,070 | ) | (1,722 | ) | (3,505 | ) | (4,227 | ) | ||||||||
Income from continuing operations | 1,655 | 2,534 | 5,863 | 6,395 | ||||||||||||
Discontinued operations: | ||||||||||||||||
Loss from discontinued operations, before income taxes | (52 | ) | (89 | ) | (154 | ) | (615 | ) | ||||||||
Income tax benefit | 15 | 17 | 51 | 217 | ||||||||||||
Loss from discontinued operations | (37 | ) | (72 | ) | (103 | ) | (398 | ) | ||||||||
Net income | $ | 1,618 | $ | 2,462 | $ | 5,760 | $ | 5,997 | ||||||||
Earnings per share: | ||||||||||||||||
Basic | ||||||||||||||||
Income from continuing operations | $ | 0.14 | $ | 0.22 | $ | 0.51 | $ | 0.56 | ||||||||
Loss from discontinued operations | — | — | (0.01 | ) | (0.03 | ) | ||||||||||
Net income | $ | 0.14 | $ | 0.22 | $ | 0.50 | $ | 0.53 | ||||||||
Diluted | ||||||||||||||||
Income from continuing operations | $ | 0.14 | $ | 0.22 | $ | 0.51 | $ | 0.55 | ||||||||
Loss from discontinued operations | — | (0.01 | ) | (0.01 | ) | (0.03 | ) | |||||||||
Net income | $ | 0.14 | $ | 0.21 | $ | 0.50 | $ | 0.52 | ||||||||
Weighted average shares outstanding: | ||||||||||||||||
Basic | 11,480 | 11,353 | 11,458 | 11,351 | ||||||||||||
Diluted | 11,578 | 11,516 | 11,571 | 11,515 | ||||||||||||
KMG CHEMICALS, INC. AND SUBSIDIARIES | ||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS | ||||||||
(In thousands, except for share and per share amounts) | ||||||||
January 31, | July 31, | |||||||
2013 | 2012 | |||||||
(Unaudited) | ||||||||
Assets | ||||||||
Current assets | ||||||||
Cash and cash equivalents | $ | 5,487 | $ | 1,633 | ||||
Accounts receivable | ||||||||
Trade, net of allowances of $93 at January 31, 2013 and $16 at July 31, 2012 | 24,767 | 28,933 | ||||||
Other | 3,590 | 960 | ||||||
Inventories, net | 43,038 | 40,661 | ||||||
Current deferred tax assets | 1,429 | 1,417 | ||||||
Prepaid expenses and other | 952 | 2,057 | ||||||
Total current assets | 79,263 | 75,661 | ||||||
Property, plant and equipment, net | 68,800 | 68,026 | ||||||
Deferred tax assets | 1,174 | 1,129 | ||||||
Goodwill | 3,778 | 3,778 | ||||||
Intangible assets, net | 14,830 | 14,980 | ||||||
Restricted cash | 1,000 | 1,000 | ||||||
Other assets, net | 3,417 | 3,116 | ||||||
Total assets | $ | 172,262 | $ | 167,690 | ||||
Liabilities and stockholders' equity | ||||||||
Current liabilities | ||||||||
Accounts payable | $ | 21,390 | $ | 21,855 | ||||
Accrued liabilities | 4,691 | 4,595 | ||||||
Employee incentive accrual | 1,203 | 2,227 | ||||||
Total current liabilities | 27,284 | 28,677 | ||||||
Long-term debt, net of current maturities | 22,000 | 24,000 | ||||||
Deferred tax liabilities | 7,040 | 7,046 | ||||||
Other long-term liabilities | 1,595 | 1,200 | ||||||
Total liabilities | 57,919 | 60,923 | ||||||
Commitments and contingencies | ||||||||
Stockholders' equity | ||||||||
Preferred stock, $0.01 par value, 10,000,000 shares authorized, none issued | — | — | ||||||
Common stock, $0.01 par value, 40,000,000 shares authorized, 11,495,273 shares issued and outstanding at January 31, 2013 and 11,405,808 shares issued and outstanding at July 31, 2012 | 115 | 114 | ||||||
Additional paid-in capital | 26,557 | 26,022 | ||||||
Accumulated other comprehensive loss | (2,372 | ) | (4,339 | ) | ||||
Retained earnings | 90,043 | 84,970 | ||||||
Total stockholders' equity | 114,343 | 106,767 | ||||||
Total liabilities and stockholders' equity | $ | 172,262 | $ | 167,690 | ||||
KMG CHEMICALS, INC. AND SUBSIDIARIES | ||||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||||
(UNAUDITED) | ||||||||
(In thousands) | ||||||||
Six Months Ended | ||||||||
January 31, | ||||||||
2013 | 2012 | |||||||
Cash flows from operating activities | ||||||||
Net income | $ | 5,760 | $ | 5,997 | ||||
Adjustments to reconcile net income to net cash provided by operating activities | ||||||||
Depreciation and amortization | 3,504 | 3,545 | ||||||
Amortization of loan costs included in interest expense | 31 | 54 | ||||||
Stock-based compensation expense | 297 | 239 | ||||||
Bad debt expense | 77 | — | ||||||
Inventory valuation adjustment | (301 | ) | 125 | |||||
(Gain)/loss on disposal of property | 9 | (44 | ) | |||||
Loss on sale of animal health business | 57 | — | ||||||
Deferred income tax expense/(benefit) | (5 | ) | 1,003 | |||||
Tax benefit from stock-based awards | (436 | ) | (121 | ) | ||||
Changes in operating assets and liabilities | ||||||||
Accounts receivable — trade | 4,437 | 5,261 | ||||||
